Drug Trial Radar · NCT05279846
A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)
Last checked: Nov 19, 2026Latest source record: Jun 26, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
350
Planned (sponsor's estimate)
Start
May 9, 2022
Primary completion
Jan 2025
Study completion Jan 2025
Sponsor
- Lead sponsor
- Moberg Pharma ABIndustry
- Sponsor type
- Industry
- First posted
- Mar 15, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 3 multicenter, double-blind study to evaluate the safety and efficacy of vehicle-controlled topical MOB015B in the treatment of Distal Subungual Onychomycosis (DSO)
Conditions
- Onychomycosis
Interventions
MOB015BDrug
Applied topically for 48 weeks
Vehicle (Placebo Comparator)Drug
Applied topically for 48 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of subjects with complete cure of the target toenailTime frame: 52 Week
- Incidence of adverse events (Safety)Time frame: 52 Week
Locations
35 sites in 2 countries. Site status is shown where the registry gives one.
University of Alabama Hospital
Birmingham, Alabama
California Dermatology & Clinical Research Institute
Encinitas, California
Center for Dermatology Clinical Research,Inc
Fremont, California
Dermatology Research Associates
Los Angeles, California
Center for Clinical Research
San Francisco, California
Colorado Medical Research Center
Denver, Colorado
Olympian Clinical Research
Clearwater, Florida
Driven Research LLC
Coral Gables, Florida
Doctors Research Institute Corporation
South Miami, Florida
Podiatry 1st
O'Fallon, Illinois
The South Bend Clinic, LLC
South Bend, Indiana
DelRicht Research - Baton Rouge
Baton Rouge, Louisiana
IMA Clinical Research
Monroe, Louisiana
David Fivenson, MD, Dermatology, PLLC
Ann Arbor, Michigan
Michigan Center for Skin Care Research
Clinton Township, Michigan
Associated Skin Care Specs
New Brighton, Minnesota
Skin Specialists, PC
Omaha, Nebraska
Hassman Research Institute
Berlin, New Jersey
Forest Hills Dermatology Group
Kew Gardens, New York
Weill Cornell Medicine Dermatology
New York, New York
Skin Search of Rochester
Rochester, New York
UNC Dermatology and Skin Cancer Center
Chapel Hill, North Carolina
Haber Dermatology, Inc.
Beachwood, Ohio
Oregon Dermatology and Research Center
Portland, Oregon
UPMC Department of Dermatology
Pittsburgh, Pennsylvania
Martin Foot and Ankle
York, Pennsylvania
Coastal Carolina Research Center
North Charleston, South Carolina
Tennessee Clinical Research Center
Nashville, Tennessee
DermResearch, Inc.
Austin, Texas
Futuro Clinical Trials LLC
McAllen, Texas
Progressive Clinical Research, PA
San Antonio, Texas
Houston Center for Clinical Research
Sugar Land, Texas
Virginia Clinical Research, Inc.
Norfolk, Virginia
Mediprobe Research
London, Ontario, Canada
Toronto Research Centre
Toronto, Ontario, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.